Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Breast Cancer Chemoprevention, Tamoxifen

Victor Vogel

MD MHS

🏢Geisinger Health System🌐USA

Professor Emeritus

48
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Victor Vogel has contributed to breast cancer chemoprevention clinical research, including contributions to the STAR trial comparing tamoxifen versus raloxifene for breast cancer risk reduction in postmenopausal women. His work on implementing risk-based chemoprevention strategies and his clinical research on breast cancer risk reduction agents have contributed to the underutilized but evidence-based chemoprevention field.

Share:

🧪Research Fields 研究领域

breast cancer chemoprevention
tamoxifen prevention
raloxifene prevention
STAR trial breast
breast cancer risk reduction

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Victor Vogel 的研究动态

Follow Victor Vogel's research updates

留下邮箱,当我们发布与 Victor Vogel(Geisinger Health System)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment